RxDoctor Payments Data

Shay Dean, MD

Plastic and Reconstructive Surgery · Marina del Rey, CANPI 1942358965

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 90.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $28,449 and has fallen 99.6% since, to $128 in 2025. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,372in general payments, 2019–2025

Across 279 payments — averaging $241.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$61K
  • Medline Industries LP$3K
  • Sientra, Inc.$2K
  • Mentor Worldwide LLC$2K
  • Integra Lifesciences Corporation$34
  • Acell, Inc.$26
  • plus $46 from 2 others

What the payments were for

  • Consulting fees$31,35447%
  • Speaking & faculty fees$16,25024%
  • Travel & lodging$7,72711%
  • Food & beverage$12,00818%
  • Gifts$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)146$60,675
Medline Industries LP58$3,044
Sientra, Inc.43$1,782
Mentor Worldwide LLC27$1,766
Integra Lifesciences Corporation2$34
Acell, Inc.1$26
Axogen1$25
Smith+Nephew1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,372 in reported general payments places this provider in the 95th percentile of 349 plastic and reconstructive surgery providers in California.

See all plastic and reconstructive surgery providers in California

Medicare billing

Part B allowed, 2024
$6,169,251
Medicare patients
15
Services billed
3,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin11$80

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Marina del Rey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →